We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
DENTSPLY SIRONA's (XRAY) first-quarter results are likely to reflect growth in the Wellspect Healthcare business and Orthodontic segment amid foreign exchange headwinds.
Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how COR, GKOS, SRDX and ARAY are placed ahead of their earnings releases.
These companies saw their stocks spike after impressively beating earnings expectations last week and more upside could be ahead considering EPS estimates for fiscal 2024 have trended higher afterwards.
Revvity's (RVTY) first-quarter results showcase a decline in life sciences segmental revenues. However, the company's earnings and revenues beat their respective estimates.
Cardinal Health's (CAH) third-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.
Hologic's (HOLX) second-quarter 2024 earnings will likely reflect gains from the GYN surgical business and the growing adoption of Panther instruments.
Here is a sneak peek into how the five medical device stocks, SYK, GEHC, ECL, NARI and MMSI, might fare in their quarterly results slated to be released tomorrow.
ResMed's (RMD) fiscal 2024 third-quarter performance reflects another strong period of execution across the entire business, resulting in impressive top and bottom-line growth.
DexCom's (DXCM) first-quarter 2024 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.
medical-devices: Archive
Ecolab (ECL) Q1 Earnings Surpass Estimates, Margins Rise
by Zacks Equity Research
Ecolab's (ECL) robust performance across the majority of its segments drives its first-quarter sales despite business challenges.
BSXNegative Net Change ECLNegative Net Change ALGNNegative Net Change DXCMNegative Net Change
earnings medical medical-devices
QIAGEN (QGEN) Q1 Earnings Top Estimates, Margins Expand
by Zacks Equity Research
QIAGEN (QGEN) Q1 results are driven by solid growth in consumables and ongoing higher instruments placements.
BSXNegative Net Change ALGNNegative Net Change DXCMNegative Net Change QGENPositive Net Change
earnings medical medical-devices
What's in Store for DENTSPLY SIRONA (XRAY) in Q1 Earnings?
by Zacks Equity Research
DENTSPLY SIRONA's (XRAY) first-quarter results are likely to reflect growth in the Wellspect Healthcare business and Orthodontic segment amid foreign exchange headwinds.
XRAYNegative Net Change BPMCNegative Net Change NVCRPositive Net Change SIBNNegative Net Change
medical medical-devices
Can the 4 Medical Device Stocks Hit Targets This Earnings Season?
by Debanjana Dey
Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how COR, GKOS, SRDX and ARAY are placed ahead of their earnings releases.
ARAYNegative Net Change SRDXNegative Net Change CORPositive Net Change GKOSPositive Net Change
earnings medical medical-devices
Veru Inc. (VERU) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
VERUNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Here's Why You Should Buy Bruker (BRKR) Stock Right Now
by Zacks Equity Research
Bruker's (BRKR) strong potential across the NANO and BioSpin segments bodes well for investors.
DXCMNegative Net Change HCAPositive Net Change BRKRNegative Net Change INSPNegative Net Change
medical medical-devices
Top Stocks to Buy with Rising EPS Estimates After Earnings
by Shaun Pruitt
These companies saw their stocks spike after impressively beating earnings expectations last week and more upside could be ahead considering EPS estimates for fiscal 2024 have trended higher afterwards.
VLONegative Net Change RMDNegative Net Change AEMPositive Net Change APPFPositive Net Change
basic-materials earnings gold inflation investing medical medical-devices oil-energy tech-stocks
Avantor (AVTR) Q1 Earnings Surpass Estimates, Margins Down
by Zacks Equity Research
Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft first-quarter performance.
BSXNegative Net Change ALGNNegative Net Change RMDNegative Net Change AVTRPositive Net Change
earnings medical medical-devices
Sustained Product Demand Likely to Aid BD's (BDX) Q2 Earnings
by Zacks Equity Research
Continued solid uptake of BD's (BDX) products is expected to have driven fiscal second-quarter revenues.
BDXPositive Net Change UHSPositive Net Change THCNegative Net Change BPMCNegative Net Change
earnings medical medical-devices
Revvity (RVTY) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Revvity's (RVTY) first-quarter results showcase a decline in life sciences segmental revenues. However, the company's earnings and revenues beat their respective estimates.
ECLNegative Net Change BDXPositive Net Change ALGNNegative Net Change RVTYPositive Net Change
earnings medical medical-devices
What's in Store for Cardinal Health (CAH) in Q3 Earnings?
by Zacks Equity Research
Cardinal Health's (CAH) third-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.
CAHPositive Net Change EWNegative Net Change NVCRPositive Net Change SIBNNegative Net Change
medical medical-devices
How You Should Play Hologic (HOLX) Ahead of Q2 Earnings
by Riya Anand
Hologic's (HOLX) second-quarter 2024 earnings will likely reflect gains from the GYN surgical business and the growing adoption of Panther instruments.
HOLXNegative Net Change INSPNegative Net Change TMDXPositive Net Change HITINegative Net Change
earnings-preview medical medical-devices
Baxter (BAX) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Baxter's (BAX) first-quarter results are likely to reflect growth in elective surgical procedures and a more stable supply chain.
BAXNegative Net Change ZBHNegative Net Change LNTHPositive Net Change VERUNegative Net Change
medical medical-devices
What's in Store for These 5 Medical Device Stocks in Q1 Earnings?
by Indrajit Bandyopadhyay
Here is a sneak peek into how the five medical device stocks, SYK, GEHC, ECL, NARI and MMSI, might fare in their quarterly results slated to be released tomorrow.
ECLNegative Net Change SYKNegative Net Change MMSIPositive Net Change NARIPositive Net Change GEHCPositive Net Change
medical medical-devices
Amedisys (AMED) Q1 Earnings Surpass Estimates, Margins Rise
by Zacks Equity Research
Amedisys (AMED) tops on revenue and earnings estimates in the first quarter of fiscal 2024.
AMEDPositive Net Change HCAPositive Net Change EHCPositive Net Change INSPNegative Net Change
earnings medical medical-devices
Philips (PHG) Receives FDA Warning Letter Regarding CT Systems
by Zacks Equity Research
Philips (PHG) receives a warning letter from the FDA in respect of a manufacturing plant in China regarding faults in the manufacturing of CT systems.
ECLNegative Net Change PHGPositive Net Change BDXPositive Net Change IDXXPositive Net Change
medical medical-devices
Factors Setting the Tone For Lantheus' (LNTH) Q1 Earnings
by Zacks Equity Research
Lantheus' (LNTH) first-quarter results are likely to reflect solid top-line performance on the back of robust product adoption.
CAHPositive Net Change EWNegative Net Change LNTHPositive Net Change SIBNNegative Net Change
medical medical-devices
Factors Setting the Tone for Ecolab's (ECL) Q1 Earnings
by Zacks Equity Research
Ecolab's (ECL) first-quarter results are likely to reflect continued segmental strength.
ECLNegative Net Change UHSPositive Net Change THCNegative Net Change BPMCNegative Net Change
earnings medical medical-devices
Integer Holdings (ITGR) Q1 Earnings Top Estimates, Margins Up
by Zacks Equity Research
Integer Holdings' (ITGR) first-quarter results reflect robust Medical Sales, along with strength in all the product lines.
LHPositive Net Change ALGNNegative Net Change RMDNegative Net Change ITGRNegative Net Change
earnings medical medical-devices
3 Medical Products Stocks Set to Beat This Earnings Season
by Urmimala Biswas
Here are three stocks, TXG, CAH and HOLX, which are expected to beat earnings estimates in the ongoing reporting cycle.
BSXNegative Net Change LHPositive Net Change CAHPositive Net Change HOLXNegative Net Change TXGNegative Net Change
earnings medical medical-devices
Edwards Lifesciences (EW) Q1 Earnings Top, 2024 Sales View Up
by Zacks Equity Research
Strong performance of SAPIEN 3 Ultra RESILIA platform and sustainable TAVR growth drives Edwards Lifesciences (EW) Q1 revenues.
EWNegative Net Change EXASNegative Net Change INSPNegative Net Change TMDXPositive Net Change
earnings medical medical-devices
Should Lifeward (LFWD) be in Your Portfolio Ahead of Q1 Earnings?
by Moumi Mondal
Lifeward's (LFWD) first-quarter 2024 results are expected to reflect the benefits of several milestone achievements from last year.
INSPNegative Net Change TMDXPositive Net Change HITINegative Net Change LFWDNegative Net Change
earnings medical medical-devices
ResMed (RMD) Q3 Earnings Beat Estimates, Margins Expand
by Zacks Equity Research
ResMed's (RMD) fiscal 2024 third-quarter performance reflects another strong period of execution across the entire business, resulting in impressive top and bottom-line growth.
RMDNegative Net Change HCAPositive Net Change INSPNegative Net Change TMDXPositive Net Change
earnings medical medical-devices
Cencora (COR) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Cencora's (COR) second-quarter fiscal 2024 results are likely to reflect solid performance in the U.S. Healthcare Solutions segment.
CAHPositive Net Change CORPositive Net Change NVCRPositive Net Change SIBNNegative Net Change
medical medical-devices
DexCom (DXCM) Q1 Earnings Beat, Strong CGM Demand Continues
by Zacks Equity Research
DexCom's (DXCM) first-quarter 2024 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.
ECLNegative Net Change BDXPositive Net Change DXCMNegative Net Change IDXXPositive Net Change
earnings medical medical-devices